Find a Clinical Trial
Filter
DEFENDO Long-Term Follow-Up Study
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
SEER-2
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
Gemini 1
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
Hercules
Multiple sclerosis
All genders
18-60
Recruiting now
Department of Neurology
PERSEUS
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
POETYK SjS-1
Sjogren's syndrome
All genders
18+
Recruiting now
Department of Ophthalmology
BALATON
Macular degeneration
All genders
18+
Recruiting now
Department of Ophthalmology
Belvedere
Macular degeneration
All genders
50+
Recruiting now
Department of Ophthalmology
KPI-012-C-001
Corneal disorders
All genders
18+
Recruiting now
Department of Ophthalmology
A clinical trial investigating BNT113 in combination with pembrolizumab versus pembrolizumab alone for patients with a form of head and neck cancer positive for human papilloma virus 16 and expressing the protein PD-L1
Head and neck cancer
All genders
18+
Recruiting now
Cancer Center